Forbes March 22, 2020
Bruce Y. Lee

Would you rather have COVID-19 causing coronavirus test results in 45 minutes or a few days?

If your answer is 45 minutes then you may be happy to see a new U.S. Food and Drug Administration (FDA) announcement about a new rapid test. But don’t rapidly jump to conclusions just yet before you hear of the details behind this emergency use authorization (EUA) approval.

The FDA has granted EUA to Cepheid for their Xpert® Xpress SARS-CoV-2 test. This is a rapid molecular diagnostic test that can detect the presence of the COVID-19 causing coronavirus. How rapid is rapid? How about returning results in 45 minutes?

That’s about a fifth of the length of the Academy Awards telecast and only about...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies, Healthcare System, Patient / Consumer, Provider, Trends
Early tests of H5N1 prevalence in milk suggest U.S. bird flu outbreak in cows is widespread
Bird Flu (H5N1) Explained: Here’s What To Know—And Why Scientists Are Concerned
2023 Had Most Food Recalls Since Start Of COVID-19 Pandemic, Report Finds
Exo adds FDA-cleared AI tools to handheld ultrasound system
Scopio Labs gains De Novo clearance for AI bone marrow analysis software and more FDA clearances

Share This Article